US 9801813
Preservative-free ophthalmic pharmaceutical formulation
granted A61KA61K31/382A61K31/535
Quick answer
US patent 9801813 (Preservative-free ophthalmic pharmaceutical formulation) held by SENTISS PHARMA PRIVATE LIMITED expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- SENTISS PHARMA PRIVATE LIMITED
- Grant date
- Tue Oct 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/382, A61K31/535, A61K31/5377, A61K45/06